These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9881957

  • 1. Variant clinical course of mucopolysaccharidosis type VII in two groups of mice carrying the same mutation.
    Casal ML, Wolfe JH.
    Lab Invest; 1998 Dec; 78(12):1575-81. PubMed ID: 9881957
    [Abstract] [Full Text] [Related]

  • 2. A novel model of murine mucopolysaccharidosis type VII due to an intracisternal a particle element transposition into the beta-glucuronidase gene: clinical and pathologic findings.
    Vogler C, Levy B, Galvin N, Sands MS, Birkenmeier EH, Sly WS, Barker J.
    Pediatr Res; 2001 Mar; 49(3):342-8. PubMed ID: 11228259
    [Abstract] [Full Text] [Related]

  • 3. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
    Derrick-Roberts AL, Pyragius CE, Kaidonis XM, Jackson MR, Anson DS, Byers S.
    Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
    [Abstract] [Full Text] [Related]

  • 4. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.
    Tomatsu S, Orii KO, Vogler C, Grubb JH, Snella EM, Gutierrez MA, Dieter T, Sukegawa K, Orii T, Kondo N, Sly WS.
    Proc Natl Acad Sci U S A; 2002 Nov 12; 99(23):14982-7. PubMed ID: 12403825
    [Abstract] [Full Text] [Related]

  • 5. Enzyme replacement therapy improves reproductive performance in mucopolysaccharidosis type VII mice but does not prevent postnatal losses.
    Soper BW, Pung AW, Vogler CA, Grubb JH, Sly WS, Barker JE.
    Pediatr Res; 1999 Feb 12; 45(2):180-6. PubMed ID: 10022587
    [Abstract] [Full Text] [Related]

  • 6. Glycosaminoglycan storage in cultured neonatal murine mucopolysaccharidosis type VII neuroglial cells and correction by beta-glucuronidase gene transfer.
    Taylor RM, Wolfe JH.
    J Neurochem; 1997 May 12; 68(5):2079-85. PubMed ID: 9109535
    [Abstract] [Full Text] [Related]

  • 7. Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells.
    Ross CJ, Bastedo L, Maier SA, Sands MS, Chang PL.
    Hum Gene Ther; 2000 Oct 10; 11(15):2117-27. PubMed ID: 11044913
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.
    Sly WS, Vogler C, Grubb JH, Zhou M, Jiang J, Zhou XY, Tomatsu S, Bi Y, Snella EM.
    Proc Natl Acad Sci U S A; 2001 Feb 27; 98(5):2205-10. PubMed ID: 11226217
    [Abstract] [Full Text] [Related]

  • 10. Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse.
    Vogler C, Levy B, Galvin N, Lessard M, Soper B, Barker J.
    Pediatr Dev Pathol; 2005 Feb 27; 8(4):453-62. PubMed ID: 16222480
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase.
    Tomatsu S, Orii KO, Vogler C, Grubb JH, Snella EM, Gutierrez M, Dieter T, Holden CC, Sukegawa K, Orii T, Kondo N, Sly WS.
    Hum Mol Genet; 2003 May 01; 12(9):961-73. PubMed ID: 12700165
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
    Xu L, Mango RL, Sands MS, Haskins ME, Ellinwood NM, Ponder KP.
    Mol Ther; 2002 Dec 01; 6(6):745-58. PubMed ID: 12498771
    [Abstract] [Full Text] [Related]

  • 14. Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII.
    Bielicki J, McIntyre C, Anson DS.
    Mol Genet Metab; 2010 Dec 01; 101(4):370-82. PubMed ID: 20864369
    [Abstract] [Full Text] [Related]

  • 15. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
    Richard M, Arfi A, Seguin J, Gandolphe C, Scherman D.
    Gene Ther; 2009 Jun 01; 16(6):746-56. PubMed ID: 19357715
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inner ear pathology in the mucopolysaccharidosis VII mouse.
    Ohlemiller KK, Hennig AK, Lett JM, Heidbreder AF, Sands MS.
    Hear Res; 2002 Jul 01; 169(1-2):69-84. PubMed ID: 12121741
    [Abstract] [Full Text] [Related]

  • 18. AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice.
    Hennig AK, Ogilvie JM, Ohlemiller KK, Timmers AM, Hauswirth WW, Sands MS.
    Mol Ther; 2004 Jul 01; 10(1):106-16. PubMed ID: 15233947
    [Abstract] [Full Text] [Related]

  • 19. Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus.
    Watson GL, Sayles JN, Chen C, Elliger SS, Elliger CA, Raju NR, Kurtzman GJ, Podsakoff GM.
    Gene Ther; 1998 Dec 01; 5(12):1642-9. PubMed ID: 10023443
    [Abstract] [Full Text] [Related]

  • 20. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII.
    Sands MS, Erway LC, Vogler C, Sly WS, Birkenmeier EH.
    Blood; 1995 Sep 01; 86(5):2033-40. PubMed ID: 7655032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.